Diagnosis and treatment of malignant pheochromocytoma with 131I-meta-iodobenzylguanidine: a case report

J. E. Konings, P. F. Bruning, N. G. Abeling, A. H. van Gennip, C. A. Hoefnagel

Research output: Contribution to journalArticleAcademicpeer-review


The case of a 67-year-old male patient with metastatic malignant pheochromocytoma is described to illustrate the significant improvement of the diagnosis and treatment of pheochromocytoma since the recent introduction of 131I-meta-iodobenzylguanidine (131I-MIBG). Because of the generally observed tumor heterogeneity as to 131I-MIBG uptake and radiosensitivity in advanced disease, treatment results may be improved further, if 131I-MIBG therapy is initiated when tumor load is still small
Original languageEnglish
Pages (from-to)103-108
JournalRadiotherapy and Oncology
Issue number2
Publication statusPublished - 1990

Cite this